Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Zigeuner

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
World Journal of Urology|August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective seriesSabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
Cancers|December 23, 2023
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder CancerLukas Scheipner, Hanna Zurl, Julia V Altziebler, et al.
European Urology|May 2, 2017
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic ReviewViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.
European Urology|January 9, 2007
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survivalPierre I Karakiewicz, Quoc-Dien Trinh, Naeem Bhojani, et al.
European Urology|August 12, 2008
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinomaBernd Wagner, Jean-Jacques Patard, Arnaud Méjean, et al.
The Journal of Urology|October 20, 2009
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?Claudio Jeldres, Maxine Sun, Daniel Liberman, et al.
BJU International|February 22, 2011
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma CollaborationRamy F Youssef, Shahrokh F Shariat, Yair Lotan, et al.
European Urology Focus|August 1, 2018
Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?Marko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|August 2, 2016
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines PanelThomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
World Journal of Urology|August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective seriesSabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
Cancers|December 23, 2023
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder CancerLukas Scheipner, Hanna Zurl, Julia V Altziebler, et al.
European Urology|May 2, 2017
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic ReviewViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.
European Urology|January 9, 2007
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survivalPierre I Karakiewicz, Quoc-Dien Trinh, Naeem Bhojani, et al.
European Urology|August 12, 2008
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinomaBernd Wagner, Jean-Jacques Patard, Arnaud Méjean, et al.
The Journal of Urology|October 20, 2009
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?Claudio Jeldres, Maxine Sun, Daniel Liberman, et al.
BJU International|February 22, 2011
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma CollaborationRamy F Youssef, Shahrokh F Shariat, Yair Lotan, et al.
European Urology Focus|August 1, 2018
Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?Marko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|August 2, 2016
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines PanelThomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al.
Pageof 17